Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension
Public ClinicalTrials.gov record NCT00362115. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study of the Efficacy, Safety and Tolerability of TAK-491 in Subjects With Mild to Moderate Uncomplicated Essential Hypertension
Study identification
- NCT ID
- NCT00362115
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 449 participants
Conditions and interventions
Conditions
Interventions
- Azilsartan Medoxomil Drug
- Olmesartan Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2006
- Primary completion
- Nov 30, 2006
- Completion
- Nov 30, 2006
- Last update posted
- Apr 18, 2011
2006
United States locations
- U.S. sites
- 46
- U.S. states
- 21
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | — | — |
| Not listed | Ozark | Alabama | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Carmichael | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Tustin | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Stamford | Connecticut | — | — |
| Not listed | Trumbull | Connecticut | — | — |
| Not listed | Waterbury | Connecticut | — | — |
| Not listed | Hollywood | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Melbourne | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Pinellas Park | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Evansville | Indiana | — | — |
| Not listed | Shawnee Mission | Kansas | — | — |
| Not listed | Auburn | Maine | — | — |
| Not listed | Trenton | New Jersey | — | — |
| Not listed | Binghamtom | New York | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Burlington | North Carolina | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Concord | North Carolina | — | — |
| Not listed | Hickory | North Carolina | — | — |
| Not listed | Salisbury | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Anderson | South Carolina | — | — |
| Not listed | Mt. Pleasant | South Carolina | — | — |
| Not listed | Simpsonville | South Carolina | — | — |
| Not listed | Bristol | Tennessee | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Euless | Texas | — | — |
| Not listed | North Richland Hills | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Lakewood | Washington | — | — |
| Not listed | Renton | Washington | — | — |
| Not listed | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00362115, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2011 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00362115 live on ClinicalTrials.gov.